Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology

Health Care

Stock price data as of

Closing price: $152.50
  • Support level
    $125.82
  • Resistance level
    N/A
  • Beta
    0.4
  • RSI (14-day)
    93.1
  • GILD is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
  • GILD is one of this month's top performers with a return of 26.4 percent, beating 90 percent of stocks in the S&P-100.
  • Volatility is forecast to fall over the next month.
  • With RSI > 70, GILD is overbought. Odds slightly favor a short-term price reversal.
  • Price broke above prior resistance level - a short-term bullish signal.

52-week range
52-week low 52-week high Price as % of range
$95.48 $152.50 100.0%

Moving averages
200 day 50 day 20 day 10 day
$116.77 $127.52 $134.51 $143.42

Value at risk (VaR)

There is an estimated 5% probability that the stock price will fall by more than VaR in time period.

  • In the next week
    7.5%
  • In the next month
    15.4%
  • In the next year
    54.5%

Volatility estimates (annualized standard deviations)
Period Value
Historical (5 year) 23.7%
Last month 24.3%
Current estimate 27.7%
Next month forecast 27.2%